Skip to content

Walking and tSCS in Non-ambulatory Stroke Survivors

Robot-assisted Gait Training and Transcutaneous Spinal Cord Stimulation in Chronic Non-ambulatory Stroke Survivors: Pilot RCT Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07226518
Enrollment
20
Registered
2025-11-10
Start date
2026-01-01
Completion date
2026-12-31
Last updated
2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke Patients, Chronic Stroke Survivors, Stroke

Keywords

stroke gait rehabilitation, Transcutaneous spinal cord stimulation, Non invasive spinal cord stimulation, Robot assisted gait training

Brief summary

Rehabilitation interventions commonly used for stroke survivors include task-specific training, balance and strength exercises, and the use of assistive devices to enhance mobility and independence. Advanced technologies, such as body-weight-supported treadmill systems and robotic devices, may be employed when appropriate. Current rehabilitation therapies for stroke survivors are moderately effective with a limited effect size, especially in stroke survivors with severe impairment. Novel therapies, such as transcutaneous spinal cord stimulation (tSCS), may further improve outcomes in the target population. This pilot study will allow us to examine the feasibility and gather pilot data on a combined intervention of assistive gait training and tSCS in non-ambulatory stroke survivors.

Interventions

DEVICERobot-assisted gait training and transcutaneous spinal cord stimulation in chronic non-ambulatory stroke survivors: pilot RCT trial

Participants in the experimental group will receive 30 minutes of robot assisted gait training (RAGT) transcutaneous spinal cord stimulation 3 times per week, 8 weeks, totaling 24 sessions. The gait training will utilize a treadmill equipped with a partial-body-weight support system and a lab-developed RAGT device. The RAGT protocol will be the same as in the control group

DEVICERobot assisted gait training alone

Participants in the control group will receive 30 minutes of assisted gait training (RAGT), 3 times per week, for 8 weeks, totaling 24 sessions. The gait training will utilize a treadmill equipped with a partial-body-weight support system and a lab-developed RAGT device

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-80 years at time of consent 2. All genders included. 3. Chronic ischemic or hemorrhagic stroke \>=6 months, with limited within-home comfortable walking speed \<= 0.49 m/s and unable to walk independently in community (FAC \<= 3) 4. Able to communicate with investigators, follow 2-step command, and correctly answer consent comprehension questions in English. 5. Currently not participating in treadmill walking exercises or exercises involving weight-bearing activities. 6. Have physicians' approval for exercise and be in a stable medical condition

Exclusion criteria

1. Hospitalization for cardiac or pulmonary disease within the past 3 months 2. Have musculoskeletal disorders that prevent the participant from participating in the exercise 3. Blood pressure higher than 200/110 mm Hg 4. Significant ataxia or unilateral spatial neglect (score of 2 on NIH stroke scale item 7 or 11) 5. Reported pain that limits or interferes with activities of daily living and physical activity/exercise 6. Diagnosis of other neurological diseases (multiple sclerosis, Alzheimer's disease, Parkinson's disease) 7. Diagnosis of severe depression (HADS score 15-21) 8. Unable to speak or understand English, and travel to the research laboratory. 9. Contraindications to tSCS and TMS

Design outcomes

Primary

MeasureTime frameDescription
Cardiac Output (Measured by Impedance Cardiography - BIOPAC MP160 System)Before and after 24 training sessions (8 weeks)Cardiac output (L/min) will be measured using an impedance cardiography system (MP160, BIOPAC Systems Inc., Goleta, California). Measurements will be done during a 6-minute walk test. Data collection for each participant will occur at approximately the same time of day (between 9:00 AM and 11:00 AM) before the first intervention session and after completion of the 24th intervention session.

Countries

United States

Contacts

Primary ContactMustapha Mangdow, PT. MS
mmangdow@kumc.edu913-2421754

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026